AEON
Price
$0.15
Change
-$0.02 (-11.76%)
Updated
Jan 17 closing price
Capitalization
12.32M
MYNDF
Price
$0.01
Change
-$0.05 (-83.33%)
Updated
Jan 3 closing price
Capitalization
2.66M
Ad is loading...

AEON vs MYNDF

Header iconAEON vs MYNDF Comparison
Open Charts AEON vs MYNDFBanner chart's image
AEON Biopharma
Price$0.15
Change-$0.02 (-11.76%)
Volume$29.86M
Capitalization12.32M
MYND Life Sciences
Price$0.01
Change-$0.05 (-83.33%)
Volume$9.5K
Capitalization2.66M
AEON vs MYNDF Comparison Chart
Loading...
AEON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AEON vs. MYNDF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEON is a Hold and MYNDF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (AEON: $0.15 vs. MYNDF: $0.01)
Brand notoriety: AEON and MYNDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AEON: 142% vs. MYNDF: 238%
Market capitalization -- AEON: $12.32M vs. MYNDF: $2.66M
AEON [@Biotechnology] is valued at $12.32M. MYNDF’s [@Biotechnology] market capitalization is $2.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AEON’s FA Score shows that 0 FA rating(s) are green whileMYNDF’s FA Score has 1 green FA rating(s).

  • AEON’s FA Score: 0 green, 5 red.
  • MYNDF’s FA Score: 1 green, 4 red.
According to our system of comparison, both AEON and MYNDF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AEON’s TA Score shows that 4 TA indicator(s) are bullish while MYNDF’s TA Score has 1 bullish TA indicator(s).

  • AEON’s TA Score: 4 bullish, 3 bearish.
  • MYNDF’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, AEON is a better buy in the short-term than MYNDF.

Price Growth

AEON (@Biotechnology) experienced а -17.03% price change this week, while MYNDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

AEON is expected to report earnings on Feb 22, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AEON($12.3M) has a higher market cap than MYNDF($2.66M). AEON YTD gains are higher at: -71.481 vs. MYNDF (-78.032). AEON has more cash in the bank: 537K vs. MYNDF (1.81K). MYNDF has less debt than AEON: MYNDF (3M) vs AEON (16.5M).
AEONMYNDFAEON / MYNDF
Capitalization12.3M2.66M463%
EBITDAN/A-273.7K-
Gain YTD-71.481-78.03292%
P/E RatioN/AN/A-
RevenueN/A1-
Total Cash537K1.81K29,718%
Total Debt16.5M3M550%
TECHNICAL ANALYSIS
Technical Analysis
AEONMYNDF
RSI
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 11 days ago
50%
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
Bearish Trend 11 days ago
46%
Bearish Trend 11 days ago
63%
MACD
ODDS (%)
Bearish Trend 11 days ago
31%
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
58%
Bearish Trend 11 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
58%
Bearish Trend 11 days ago
39%
Advances
ODDS (%)
Bullish Trend 16 days ago
71%
N/A
Declines
ODDS (%)
Bearish Trend 19 days ago
83%
N/A
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
57%
N/A
Aroon
ODDS (%)
Bullish Trend 11 days ago
46%
N/A
View a ticker or compare two or three
Ad is loading...
AEON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MI2.840.23
+8.81%
NFT Limited
UMC6.280.07
+1.13%
United Microelectronic Corp
ABL7.450.07
+0.95%
Abacus Life
QTWO93.910.55
+0.59%
Q2 Holdings
GEVO2.20N/A
N/A
Gevo

MYNDF and

Correlation & Price change

A.I.dvisor tells us that MYNDF and NERV have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MYNDF and NERV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNDF
1D Price
Change %
MYNDF100%
N/A
NERV - MYNDF
29%
Poorly correlated
+3.72%
ICCC - MYNDF
23%
Poorly correlated
+5.16%
CSBR - MYNDF
20%
Poorly correlated
-1.71%
AEON - MYNDF
7%
Poorly correlated
-9.89%
INKT - MYNDF
4%
Poorly correlated
+5.77%
More